Orthofix Medical Inc.

Orthofix Medical Inc. is a U.S.-based global medical technology company focused on musculoskeletal care. Through its subsidiaries and operating segments, it develops and markets spinal hardware, bone growth therapies, limb reconstruction solutions, biologics, and enabling technologies such as the 7D FLASH Navigation System.

−0,5 %

68,8 %

−11,2 %

+2,9 %

2.45

1.43

— Orthofix Medical Inc.
%
Global Spine84% Implantable spinal devices, biologics, and navigation tools used in spine surgery.
Global Limb Reconstruction16% Orthopedic devices and procedural solutions for limb reconstruction and deformity correction.
Bone Growth Therapies35% External and implant-adjacent therapies used to support bone healing and fracture care.
Biologics15% Allograft and cellular bone products used in spinal and orthopedic procedures.
Enabling Technologies10% Navigation and planning systems that support surgical workflow and placement accuracy.
Limb Reconstruction Solutions16% Devices and single-use procedural packs for reconstructive orthopedic surgery.

Orthofix sells primarily to physicians, hospitals, ambulatory surgery centers, integrated delivery systems, and other...

  • Hospitals and health systemsprimary

    Buy spinal implants, biologics, navigation systems, and limb reconstruction products for surgical procedures and standardization across facilities.

  • Physicians and surgeonsprimary

    Influence product selection and adoption based on clinical workflow, ease of use, and patient outcomes.

  • Ambulatory surgery centerssecondary

    Purchase procedure-ready orthopedic and spine solutions for outpatient surgical settings.

  • Independent distributors and sales agentsprimary

    Buy or consign products and place them with end customers, especially outside the U.S.

  • Integrated delivery systems and purchasing organizationssecondary

    Evaluate and approve product portfolios for network-wide use and reimbursement alignment.

Orthofix is headquartered in Lewisville, Texas and operates as a global business with products distributed worldwide...

  • •Headquartered in Lewisville, Texas, United States
  • •U.S. sales are largely commercial revenue from hospital procedures
  • •International sales use direct reps and stocking distributors
  • •Products are distributed worldwide across spine and orthopedics
  • •Geography affects reimbursement, regulation, and channel mix

Orthofix’s strategy centers on broadening its spine and orthopedic portfolio while using clinical education, planning...

01
Broaden the musculoskeletal product portfoliomedium-term

A wider portfolio increases procedure coverage and cross-selling across spine and orthopedics.

02
Increase adoption of enabling technologiesmedium-term

Navigation and planning tools can differentiate the company and support surgeon loyalty.

03
Expand distribution and sales coverageshort-term

Distributor and agent networks extend reach into territories where direct selling is less efficient.

Orthofix faces intense competition in spine and orthopedics, where product innovation, surgeon preference,...

high

Integration of legacy businesses

The company continues to integrate businesses from different market segments, and expected synergies may not be fully realized.

Scope
Combined company structure after the SeaSpine merger
Materiality
high
high

Market acceptance and reimbursement

Hospitals, physicians, and third-party payors must accept and reimburse products for adoption to scale.

Scope
Spine, biologics, and orthopedic procedures
Materiality
high
high

Regulatory and clinical development delays

Third-party study partners and regulatory processes can delay clearance or commercialization.

Scope
New products and line extensions
Materiality
high
medium

Competitive pressure

Large medical device companies and niche innovators compete on technology, price, and surgeon preference.

Scope
Spine, biologics, limb reconstruction, and navigation
Materiality
high
medium

Goodwill impairment

Acquisition accounting and changes in market value can trigger impairment charges if reporting unit value declines.

Scope
Global Spine and acquired assets
Materiality
high
Revenue recognition for consigned and stocking-distributor sales
Net sales and gross profit
Commercial revenue recognition
Quarterly revenue timing
Goodwill impairment
Operating income and net income
Allowance for expected credit losses
Bad debt expense and balance sheet valuation
Contingent milestone payments
Liabilities and expense recognition

ORTHOPEDIATRICS CORP

KIDS · Surgical & Medical Instruments & Apparatus

SI-BONE, Inc.

SIBN · Surgical & Medical Instruments & Apparatus

Neuraxis, INC

NRXS · Electromedical & Electrotherapeutic Apparatus

TREACE MEDICAL CONCEPTS, INC.

TMCI · Surgical & Medical Instruments & Apparatus

Alphatec Holdings, Inc.

ATEC · Surgical & Medical Instruments & Apparatus

BiomX Inc.

PHGE · Biological Products, (No Diagnostic Substances)

: 29.4.2026